0001209191-21-052744.txt : 20210820 0001209191-21-052744.hdr.sgml : 20210820 20210820160241 ACCESSION NUMBER: 0001209191-21-052744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210819 FILED AS OF DATE: 20210820 DATE AS OF CHANGE: 20210820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolchko J Scott CENTRAL INDEX KEY: 0001586893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 211193818 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-19 0 0001434316 FATE THERAPEUTICS INC FATE 0001586893 Wolchko J Scott C/O FATE THERAPEUTICS, INC.; 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 1 1 0 0 President and CEO Common Stock 2021-08-19 4 M 0 20000 4.835 A 413793 D Common Stock 2021-08-19 4 S 0 20000 88.0102 D 393793 D Stock Option (Right to Buy) 4.835 2021-08-19 4 M 0 20000 0.00 D 2025-01-04 Common Stock 20000 4846 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020. This option is fully vested. /s/ Cindy Tahl, Attorney-in-Fact 2021-08-20